The Company expects to submit the New Drug Application for Xulane Lo in the second half of 2025. A low dose combination hormonal patch was found to be effective for pregnancy prevention based on ...
(Exeltis), a global pharmaceutical company specializing in women’s health, announced that the U.S. Food and Drug Administration (FDA) has approved an update to the labeled strength of TWIRLA® ...
Not getting your period after you go off birth control can be concerning, but it’s fairly common. Learn what happens to your ...
- UNDATED HANDOUT PHOTO - Johnson & Johnson won U.S. approval to sell Ortho Evra, the first contraceptive skin patch, the Food and Drug Administration said November 20, 2001. The patch releases ...